Literature DB >> 12934985

A computer algorithm for calculating the adequacy of antidepressant treatment in unipolar and bipolar depression.

Maria A Oquendo1, Enrique Baca-Garcia, Alexei Kartachov, Vadim Khait, Carl E Campbell, Monique Richards, Harold A Sackeim, Joan Prudic, J John Mann.   

Abstract

BACKGROUND: Major depression is often treated with medications in doses that are too low or too short in duration. We published an early version of the Antidepressant Treatment History Form (ATHF) that rates the adequacy of antidepressant treatment. The updated ATHF presented here includes newer medications and a computer algorithm to automate the evaluation of the adequacy of pharmacotherapy or electroconvulsive therapy for depression.
METHOD: The computer algorithm was written in MS-DOS Q-BASIC and in Visual Basic 5.0. Treatment data from 47 depressed (Structured Clinical Interview for DSM-III-R) patients were scored by the computer algorithm and assigned a number from 0 to 5 for the adequacy of antidepressant treatment. A psychiatrist blinded to the computer ratings manually rated the treatment using the ATHF.
RESULTS: The computer algorithm, based on an updated version of the ATHF, estimates the adequacy of treatment of unipolar and bipolar depression. Computer algorithm results agreed with those generated by a clinician completing the form manually (kappa = 0.88 to 1.00).
CONCLUSION: The computer algorithm can be used to analyze large databases and may help reduce the morbidity and mortality associated with major depression by improving the assessment of adequacy of pharmacologic treatments for research and quality assurance purposes. The availability of the updated ATHF on the Internet for downloading allows for modifications according to the user's purposes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12934985     DOI: 10.4088/jcp.v64n0714

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  29 in total

1.  Combining moderators to identify clinical profiles of patients who will, and will not, benefit from aripiprazole augmentation for treatment resistant late-life major depressive disorder.

Authors:  Stephen F Smagula; Meredith L Wallace; Stewart J Anderson; Jordan F Karp; Eric J Lenze; Benoit H Mulsant; Meryl A Butters; Daniel M Blumberger; Breno S Diniz; Francis E Lotrich; Mary Amanda Dew; Charles F Reynolds
Journal:  J Psychiatr Res       Date:  2016-07-07       Impact factor: 4.791

2.  Depression Remission Rates Among Older Black and White Adults: Analyses From the IRL-GREY Trial.

Authors:  Charles A Hall; Kevin M Simon; Eric J Lenze; Mary Amanda Dew; Amy Begley; Meryl A Butters; Daniel M Blumberger; Jacqueline A Stack; Benoit Mulsant; Charles F Reynolds
Journal:  Psychiatr Serv       Date:  2015-08-17       Impact factor: 3.084

3.  Methodological issues in conducting treatment trials for psychological nonepileptic seizures.

Authors:  W Curt LaFrance; Andrew S Blum; Ivan W Miller; Christine E Ryan; Gabor I Keitner
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2007       Impact factor: 2.198

4.  Self-reported obstructive sleep apnea is associated with nonresponse to antidepressant pharmacotherapy in late-life depression.

Authors:  Lauren Waterman; Sarah T Stahl; Daniel J Buysse; Eric J Lenze; Daniel Blumberger; Benoit Mulsant; Meryl Butters; Marie Anne Gebara; Charles F Reynolds; Jordan F Karp
Journal:  Depress Anxiety       Date:  2016-09-16       Impact factor: 6.505

5.  Effect of Continuing Olanzapine vs Placebo on Relapse Among Patients With Psychotic Depression in Remission: The STOP-PD II Randomized Clinical Trial.

Authors:  Alastair J Flint; Barnett S Meyers; Anthony J Rothschild; Ellen M Whyte; George S Alexopoulos; Matthew V Rudorfer; Patricia Marino; Samprit Banerjee; Cristina D Pollari; Yiyuan Wu; Aristotle N Voineskos; Benoit H Mulsant
Journal:  JAMA       Date:  2019-08-20       Impact factor: 56.272

6.  Antidepressant adequacy and work status among medicaid enrollees with disabilities: a restriction-based, propensity score-adjusted analysis.

Authors:  Eric G Smith; Alexis D Henry; Jianying Zhang; Fred Hooven; Steven M Banks
Journal:  Community Ment Health J       Date:  2009-10

7.  Empirically derived decision trees for the treatment of late-life depression.

Authors:  Carmen Andreescu; Benoit H Mulsant; Patricia R Houck; Ellen M Whyte; Sati Mazumdar; Alexandre Y Dombrovski; Bruce G Pollock; Charles F Reynolds
Journal:  Am J Psychiatry       Date:  2008-05-01       Impact factor: 18.112

8.  Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment.

Authors:  Matthew S Milak; Ramin V Parsey; Leilani Lee; Maria A Oquendo; Doreen M Olvet; Francoise Eipper; Kevin Malone; J John Mann
Journal:  Psychiatry Res       Date:  2009-05-14       Impact factor: 3.222

9.  Antidepressant Response Trajectories and Associated Clinical Prognostic Factors Among Older Adults.

Authors:  Stephen F Smagula; Meryl A Butters; Stewart J Anderson; Eric J Lenze; Mary Amanda Dew; Benoit H Mulsant; Francis E Lotrich; Howard Aizenstein; Charles F Reynolds
Journal:  JAMA Psychiatry       Date:  2015-10       Impact factor: 21.596

Review 10.  Noninvasive techniques for probing neurocircuitry and treating illness: vagus nerve stimulation (VNS), transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS).

Authors:  Mark S George; Gary Aston-Jones
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.